Home/Pipeline/Montelukast Amorphous Form

Montelukast Amorphous Form

Asthma

Phase-2Active

Key Facts

Indication

Asthma

Phase

Phase-2

Status

Active

Company

Indian‑based API and generic drug manufacturer with USFDA‑approved plants and a growing CDMO business.

Drug	Company	Phase	Status
Technegas® for Asthma	Cyclomedica	Phase 2	Active
Asthma Candidate	Teva	Phase 3	Active
Chitinase Inhibitor	Lead Discovery Siena	Discovery	Active
RIG-101	RIGImmune	Pre-clinical	Active
SKB378	Klus Pharma	Phase 1	Active
Asthma Clinical Trials	American Health Research	Not Disclosed	Active
Advanced Asthma Products	Polpharma	Not Disclosed	Active
Solrikitug	Uniquity Bio	Phase 2	Active
Asthma Trial	Science 37	Phase 3	Completed/Highlighted
CAL-4	Calyxha Biotechnologies	Preclinical	Active
Digital Biomarker for Asthma	electronRx	Early Development	Active
Flutiform	KYORIN Pharmaceutical	Marketed	Active